|
gptkbp:instanceOf
|
Neuroendocrine tumor
|
|
gptkbp:affectsOrgan
|
gptkb:Gastrointestinal_tract
Lung
|
|
gptkbp:associatedWith
|
gptkb:Neurofibromatosis_type_1
gptkb:Multiple_endocrine_neoplasia_type_1
|
|
gptkbp:canBeBenign
|
Yes
|
|
gptkbp:canBeMalignant
|
Yes
|
|
gptkbp:canMetastasizeTo
|
Yes
|
|
gptkbp:cause
|
gptkb:Flushing
gptkb:Carcinoid_syndrome
Diarrhea
Wheezing
Heart valve lesions
|
|
gptkbp:detects
|
gptkb:CT_scan
MRI
PET scan
Octreotide scan
Urinary 5-HIAA test
|
|
gptkbp:diagnosedBy
|
Imaging
Biopsy
Chromogranin A test
|
|
gptkbp:firstDescribed
|
gptkb:Siegfried_Oberndorfer
1907
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Carcinoid tumor
|
|
gptkbp:ICD-10_code
|
C7A
|
|
gptkbp:isSlowGrowing
|
Yes
|
|
gptkbp:originatedIn
|
Enterochromaffin cells
Neuroendocrine cells
|
|
gptkbp:prognosis
|
Generally favorable if localized
Poor if metastatic
|
|
gptkbp:secretes
|
gptkb:Serotonin
Histamine
Prostaglandins
Bradykinin
|
|
gptkbp:synonym
|
Carcinoid
Well-differentiated neuroendocrine tumor
|
|
gptkbp:treatment
|
gptkb:Somatostatin_analogs
Surgery
Chemotherapy
Radiotherapy
Ablation therapy
Interferon alpha
Liver embolization
Peptide receptor radionuclide therapy
|
|
gptkbp:website
|
gptkb:Rectum
Small intestine
Appendix
Bronchus
|
|
gptkbp:bfsParent
|
gptkb:Neuroendocrine_Tumor
|
|
gptkbp:bfsLayer
|
6
|